More than 20% of total rail carloads stem from the coal industry. Because of this reliance on coal shipments, CSX (NYSE: CSX ) and Norfolk Southern (NYSE: NSC ) each saw revenues from coal shipments drop by double digits in the first quarter of 2013 versus the same quarter last year. This also can't be great news for Warren Buffett's Berkshire Hathaway (NYSE: BRK-A ) , as it owns BNSF railroads, which holds a 33% market share in coal shipments by rail, according to 2012 data.
These companies cater to the eastern United States, which has seen its coal industry hurt to a much greater degree than miners out west, such as Peabody Energy and its Powder River Basin thermal coal production. Coal from this region is produced further down the cost curve and is competitive with much lower natural gas prices than the Appalachian output.
Because exports are becoming a much bigger part of the domestic coal landscape, CSX has chosen to focus on providing greater access to a variety of export terminals. Peabody Energy is just one company that has deals in place to get its cheaper coal from the Powder River and Illinois basins to India, China, and the EU. For investors looking to capitalize on a rebound in the U.S. coal market, The Motley Fool has authored a special new premium report detailing exactly why Peabody Energy is perhaps most worthy of your consideration. Don't miss out on this invaluable resource -- simply click here now to claim your copy today.
Best Supermarket Stocks To Own For 2015: Open Text Corporation (OTEX)
Open Text Corporation develops, markets, sells, licenses, and supports enterprise content management (ECM) solutions primarily in North America and Europe. The company?s ECM software and solutions enable customers to manage various types of enterprise content, including business documents, Web content, records, digital assets, email, forms and reports, forums, blogs, wikis, and real time instant messaging and collaboration. Its ECM solutions comprise various components, including document management, which provides repository for business documents, such as Microsoft office, CAD, and PDF; collaboration that offers tools designed to better facilitate people working with each other with content and processes; Web content management, which provides tools for authoring, maintaining, and administering sophisticated Web sites; and records management that enables control of the lifecycle of content objects by associating robust retention and disposition rules with each content as set. The company?s ECM solutions also provide email management services designed to enable the archiving, control, and monitoring of email; capture and delivery tools that provide the means of converting documents from analog sources; digital asset management; business process management services; content reporting tools for analyzing content and generating reports; and Open Text Everywhere that allows the Open Text ECM suite to be available via mobile devices. In addition, it offers industry specific solutions for government, technology/manufacturing, energy, financial services, pharmaceutical and life sciences, legal, and media sectors. Additionally, the company provides learning, consulting, hosting, and customer support and training services. It has strategic alliances with Microsoft Corporation, Oracle Corporation, and SAP AG. The company was founded in 1991 and is headquartered in Waterloo, Canada.
Advisors' Opinion:- [By Roberto Pedone]
Open Text (OTEX) is engaged in providing a suite of information management software products. This stock closed up 1% at $67.93 in Monday's trading session.
Monday's Volume: 736,000
Three-Month Average Volume: 225,916
Volume % Change: 198%From a technical perspective, OTEX trended modestly higher here right above some near-term support levels at $66 to $64.47 with above-average volume. This move is starting to push shares of OTEX within range of triggering a near-term breakout trade. That trade will hit if OTEX manages to take out its 50-day moving average at $69.63 with high volume.
Traders should now look for long-biased trades in OTEX as long as it's trending above $66 or $65 and then once it sustains a move or close above its 50-day at $69.63 with volume that hits near or above 225,916 shares. If that breakout triggers soon, then OTEX will set up to re-test or possibly take out its next major overhead resistance levels at $72.44 to its 52-week high at $73.77.
- [By Jake L'Ecuyer]
Shares of Open Text (NASDAQ: OTEX) got a boost, shooting up 11.95 percent to $101.45 after the company reported upbeat Q2 results and announced a 2-for-1 stock split.
Top 5 Railroad Stocks To Own Right Now: Catalyst Pharmaceutical Partners Inc.(CPRX)
Catalyst Pharmaceutical Partners, Inc., a development-stage biopharmaceutical company, focuses on the development and commercialization of prescription drugs targeting diseases of the central nervous system with a focus on the treatment of drug addiction and epilepsy. It is evaluating its lead product candidate, CPP-109, a GABA aminotransferase inhibitor candidate, which is under Phase II(b) clinical trial for the treatment of cocaine addiction, as well as focuses on evaluating CPP-109 for the treatment of other addictions and obsessive-compulsive disorders. The company is also developing CPP-115, a GABA aminotransferase inhibitor for various indications, including drug addiction, epilepsy, and for other selected central nervous disease indications. It has license agreements with Brookhaven Science Associates, LLC on various patents and patent applications relating to the use of vigabatrin as a treatment for cocaine and other addictions, and obsessive-compulsive disorders; and with Northwestern University to commercialize GABA aminotransferase inhibitors worldwide, as well as a definitive clinical trial agreement with the National Institute on Drug Abuse to jointly conduct a U.S. Phase II(b) clinical trial evaluating CPP-109 for the treatment of cocaine addiction. Catalyst Pharmaceutical Partners, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Advisors' Opinion:- [By Roberto Pedone]
One under-$10 biopharmaceutical player that's starting to move within range of triggering a big breakout trade is Catalyst Pharmaceutical Partners (CPRX), which is focused on the development and commercialization of prescription drugs targeting diseases of the central nervous system with a focus on the treatment of drug addiction and epilepsy. This stock has been on fire so far in 2013, with shares up a whopping 364%.
If you take a look at the chart for Catalyst Pharmaceutical Partners, you'll notice that this stock has been uptrending strong for the last month, with shares soaring higher from its low of $1.29 to its intraday high of $2.09 a share. During that uptrend, shares of CPRX have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed share of CPRX within range of triggering a big breakout trade.
Traders should now look for long-biased trades in CPRX if it manages to break out above its 50-day moving average of $2.11 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average volume of 2.21 million shares. If that breakout triggers soon, then CPRX will set up to re-test or possibly take out its next major overhead resistance levels at $2.87 to $3 a share. Any high-volume move above those levels will then give CPRX a chance to re-test its 52-week high at $3.65 a share.
Traders can look to buy CPRX off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $1.65 to $1.63 a share. One can also buy CPRX off strength once it starts to take out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Paul Ausick]
Stocks on the move: Catalyst Pharmaceutical Partners Inc. (NASDAQ: CPRX) is up about 40% at $1.98 after its firdapse drug treatment for certain kinds of muscle weakness was designated a breakthrough therapy by the FDA. Food maker Dean Foods Inc. (NYSE: DF) held a 1-for-2 reverse stock split this morning and the shares are up about 95%, as might be expected.
Top 5 Railroad Stocks To Own Right Now: Codexis Inc.(CDXS)
Codexis, Inc. engages in the production of custom industrial enzymes for use in the manufacture of biofuels, chemicals, and pharmaceutical ingredients. The company offers Codex Biocatalyst Panels and Kits to pharmaceutical companies that are engaged in drug development and the marketing of approved drugs to allow them to screen and identify possible enzymatic manufacturing processes for their drug candidates and their marketed products. It also provides enzyme screening services, enzyme optimization services, and enzymes, as well as supplies intermediates and active pharmaceutical ingredients to pharmaceutical companies. In addition, the company develops CodeXyme cellulase enzymes to convert cellulosic biomass, a non-food plant material into affordable sugars, which can then be converted into renewable fuels and chemicals; and CodeXol detergent alcohols that are used to manufacture surfactants, which are used as cleaning ingredients in consumer products, such as shampoos, liquid soaps, and laundry detergents. It intends to market CodeXyme cellulase enzymes to chemicals manufacturers; and CodeXol detergent alcohols as a drop-in substitute for the detergent alcohols market. The company has strategic collaborations with Royal Dutch Shell plc and Iogen Energy Corporation for the production of cellulosic ethanol from wheat straw and corn stover feedstocks. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.
Advisors' Opinion:- [By Maxx Chatsko]
Synthetic biology company and industrial bio-enzyme manufacturer�Codexis (NASDAQ: CDXS ) announced its first-quarter earnings after the market closed Tuesday. The industrial enzyme firm is still attempting to get back on its feet after Shell (NYSE: RDS-A ) ended a major collaboration in the second half of 2012. The partnership provided more than $350 million to Codexis over several years, so it is easy to see how the developmental-stage company has foundered since. Despite continued losses, it appears that Codexis is slowly climbing back to a bright future. Here is what investors need to know about the latest developments.
- [By Maxx Chatsko]
He believes several companies have set the bar precipitously low to start the year despite targeted developments expected to occur before the start of 2014. Watch the following video for his thoughts on potential positive surprises awaiting investors in�Amyris� (NASDAQ: AMRS ) ,�BioAmber� (NYSE: BIOA ) ,�Codexis� (NASDAQ: CDXS ) , and�Solazyme� (NASDAQ: SZYM ) .
- [By Maxx Chatsko]
The company will now compete more readily with industry leaders Novozymes from Novo Nordisk (NYSE: NVO ) and Genencor from DuPont (NYSE: DD ) . However, the biggest effects could be felt at Codexis (NASDAQ: CDXS ) , which has also licensed the cutting-edge host organism from Dyadic. Will BASF's push into industrial enzymes, specifically using the C1 platform, vindicate Codexis or shove it out of the way?
- [By Laura Brodbeck]
Tuesday
Earnings Expected: The Bon-Ton Stores, Inc (NASDAQ: BONT), American Eagle Outfitters, Inc (NYSE: AEO), Codexis, Inc. (NASDAQ: CDXS), Verifone Systems, Inc. (NYSE: PAY), Caesars Entertainment Corporation (NASDAQ: CZR) Economic Releases Expected: Indian trade balance, German trade balance, British industrial production, British manufacturing productionWednesday
Top 5 Railroad Stocks To Own Right Now: Energy Transfer Equity L.P. (ETE)
Energy Transfer Equity, L.P., through its direct and indirect investments in the limited partner and general partner interests in Energy Transfer Partners, L.P., engages in midstream, intrastate, and interstate transportation of natural gas, as well as in storage of natural gas in the United States. The company?s Intrastate Transportation and Storage segment engages in the ownership and operation of natural gas transportation pipelines and natural gas storage facilities. As of December 31, 2009, it owned and operated approximately 7,800 miles of natural gas transportation pipelines and 3 natural gas storage facilities. This segment sells natural gas to electric utilities, independent power plants, local distribution companies, industrial end-users, and other marketing companies on the Houston pipeline system. Its Interstate Transportation segment involves owns and operates interstate natural gas pipeline. It owned and operates approximately 2,700 miles of interstate natura l gas pipeline with an additional 180 miles under construction. The company?s Midstream segment engages in the ownership and operation of in service natural gas gathering pipelines, natural gas processing plants, natural gas treating facilities, and natural gas conditioning facilities. This segment owned and operated approximately 7,000 miles of in service natural gas gathering pipelines, 3 natural gas processing plants, 11 natural gas treating facilities, and 11 natural gas conditioning facilities. Its Retail Propane segment operates a retail distribution network consisting of approximately 440 customer service locations in approximately 40 states. The company was formerly known as La Grange Energy, L.P. Energy Transfer Equity, L.P. was founded in 2002 and is based in Dallas, Texas.
Advisors' Opinion:- [By Roberto Pedone]
Energy Transfer Equity (ETE) owns and operates natural gas gathering systems, natural gas intrastate pipeline systems and gas processing plants. This stock closed up 1.8% at $66.21 in Wednesday's trading session.
Wednesday's Volume: 4.58 million
Three-Month Average Volume: 1.28 million
Volume % Change: 321%From a technical perspective, ETE spiked higher here right off some near-term support at $63.90 with heavy upside volume. This move pushed shares of ETE into new 52-week high territory, since the stock took out some resistance at $66.97. At last check, ETE hit an intraday high of $67.90 with volume that was substantially above its three-month average action of 1.28 million shares.
Traders should now look for long-biased trades in ETE as long as it's trending above support at $63.90 or above more support at $62 and then once it sustains a move or close above its new 52-week high at $67.90 with volume that's near or above 1.28 million shares. If we get that move soon, then ETE will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $70 to $75.
No comments:
Post a Comment